Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Ryosuke Nakahara"'
Publikováno v:
Clinical Case Reports, Vol 9, Iss 8, Pp n/a-n/a (2021)
Abstract Fixed dose regimen is currently the standard administration method for TKI. However, this case report indicated that TDM may by a useful approach to individualized dosing of TKI for the treatment of CML when initiating dialysis.
Externí odkaz:
https://doaj.org/article/75389b00c752446dbfbb7fe0bd6d5f3b
Publikováno v:
Clinical Case Reports, Vol 7, Iss 7, Pp 1419-1421 (2019)
Abstract Fixed dosage regimen is currently the standard therapy with tyrosine kinase inhibitors (TKI). This case report demonstrates successful determination of nilotinib dosage by therapeutic drug monitoring (TDM) in a patient with chronic myeloid l
Externí odkaz:
https://doaj.org/article/b4ad732e676340f3a5e4cbae0604d501
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 46:303-313
Publikováno v:
Clinical Case Reports
Fixed dose regimen is currently the standard administration method for TKI. However, this case report indicated that TDM may by a useful approach to individualized dosing of TKI for the treatment of CML when initiating dialysis.
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 48(7)
At the Oita University Hospital, we switched from using the original biological product of trastuzumab(original product) to a biosimilar product, and verified the appropriateness of the switch by investigating the occurrence of adverse events. We com
Autor:
Hiroki Itoh, Takahiro Sumimoto, Masao Ogata, Ryosuke Nakahara, Yosuke Suzuki, Natsumi Yoshida, Ryota Tanaka
Publikováno v:
Therapeutic drug monitoring. 44(3)
Background Breakpoint cluster region-Abelson (BCR-ABL) tyrosine kinase inhibitors (TKIs) demonstrate improved therapeutic efficacy in chronic myeloid leukemia (CML). However, drug-drug interactions, non-adherence, and host-related factors may influen
Imatinib is used as first-line treatment for chronic myeloid leukemia (CML) even in patients with impaired renal function. We successfully used therapeutic drug monitoring to determine the dose for re-administration of imatinib in a CML patient who i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c7b04a80d60e4e5403dfaae5b39fde4
https://doi.org/10.22541/au.161091477.70557649/v1
https://doi.org/10.22541/au.161091477.70557649/v1
Publikováno v:
Journal of Clinical Laboratory Analysis. 30:1028-1030
Background A method for determining nilotinib concentration in human plasma is proposed using high-performance liquid chromatography and ultraviolet detection. Materials & Methods Nilotinib and the internal standard dasatinib were separated using a m
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 44(4)
Because generic medicines reduce the financialburden on patients and medicalinsurance providers, they have become increasingly popular. However, there are only a few reports that have analyzed the efficacy and safety of generic medicines, especially
Autor:
Rika Yanagihara, Satoshi Tanaka, Masahiko Hirata, Ryosuke Nakahara, Takako Yamaguchi, Hitoshi Matsumura, Makio Shibano, Masanori Takaoka, Kimiye Baba, Yoshikazu Fujita, Masahiko Taniguchi, Mitsunobu Doi, Mamiko Asano, Yuko Hayashi, Minoru Sakaguchi
Publikováno v:
Journal of Bioscience and Bioengineering. 118:98-100
Rhodamine B hydrazide can be used to detect hydroxyl radicals in plant cells. RBH was easily inserted into plant cells without any pretreatment, and specifically reacted with intracellular hydroxyl radicals produced by antimycin A. RBH will be a powe